Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cross-over comparative study of inhaled mannitol with and without rhDNase in children with cystic fibrosis
2004-001888-21Phase 2Completed
- Sponsor
- Pharmaxis
- Start
- Feb 2005
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Bronchitol and dornase alfa in cystic fibrosis (CF) (3 arms), sponsored by Pharmaxis. Primary endpoint: Forced Expiratory Volume in one second (FEV1). Started Feb 2005; status: completed.
02
Drugs
Bronchitoldornase alfa
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2004-001888-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001888-21.